(BCPC) Balchem - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0576652004
BCPC: Food, Ingredients, Animal, Feed, Nutrients, Chemicals, Industrial
Balchem Corporation (NASDAQ:BCPC) is a global developer, manufacturer, and supplier of specialty performance ingredients and products tailored for diverse industries, including nutrition, food, pharmaceuticals, animal health, medical device sterilization, plant nutrition, and industrial applications. The company operates through three distinct business segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment focuses on delivering advanced ingredients to the food and beverage sector, offering solutions such as spray-dried and emulsified powders, extruded and agglomerated products, blended lipid systems, and liquid flavor delivery systems. It also provides specialized components like vitamin K2, microencapsulation solutions, and human-grade choline nutrients and mineral amino acid chelates for enhanced nutritional and health benefits. The Animal Nutrition & Health segment specializes in improving the health and productivity of livestock through microencapsulated products that enhance nutrient delivery and milk production in ruminant animals. It also offers chelation technology for improved nutrient absorption across various animal species, along with methylsulfonylmethane (MSM) and choline chloride for monogastric animal health. The Specialty Products segment serves the healthcare and agricultural industries by distributing ethylene oxide and ammonia for sterilization purposes, as well as single-use canisters for sterilizing reusable medical devices. Additionally, it markets propylene oxide as a fumigant to control insects and microbiological spoilage in food products like nuts, spices, and cocoa derivatives. The segment also provides chelated minerals for high-value crops to enhance agricultural yields. Balchem Corporation, founded in 1967 and headquartered in Montvale, New Jersey, distributes its products through a combination of its direct sales force, independent distributors, and sales agents. Its strategic focus on innovation, quality, and customer-centric solutions has positioned it as a leader in the specialty chemicals industry.
3-Month Forecast: Based on the provided technical and fundamental data, Balchem Corporation (BCPC) is expected to experience a period of consolidation in the near term. The stock is currently trading below its 20-day and 50-day Simple Moving Averages (SMA), which are at 159.60 and 164.54, respectively. However, the 200-day SMA of 168.22 indicates long-term bullish momentum. The Average True Range (ATR) of 5.21 suggests moderate volatility, with potential price fluctuations within a narrow range. Fundamental analysis highlights a P/E ratio of 41.20, reflecting strong earnings expectations, while the forward P/E of 34.60 signals anticipated growth. The P/S ratio of 5.51 indicates a premium valuation relative to its revenue. Over the next three months, BCPC is likely to trade within a range bounded by support at 145.00 (near the lower end of its recent ATR range) and resistance at 170.00 (aligned with its 200-day SMA). Market participants may look for potential upside if the stock regains momentum above its 50-day SMA.
Additional Sources for BCPC Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
BCPC Stock Overview
Market Cap in USD | 5,106m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Specialty Chemicals |
IPO / Inception | 1986-06-03 |
BCPC Stock Ratings
Growth Rating | 52.4 |
Fundamental | 56.4 |
Dividend Rating | 46.8 |
Rel. Strength | 14.7 |
Analysts | 4/5 |
Fair Price Momentum | 149.43 USD |
Fair Price DCF | 80.92 USD |
BCPC Dividends
Dividend Yield 12m | 0.54% |
Yield on Cost 5y | 1.04% |
Annual Growth 5y | 8.45% |
Payout Consistency | 98.2% |
BCPC Growth Ratios
Growth Correlation 3m | -44% |
Growth Correlation 12m | 16.6% |
Growth Correlation 5y | 73.4% |
CAGR 5y | 13.48% |
CAGR/Max DD 5y | 0.40 |
Sharpe Ratio 12m | 0.52 |
Alpha | 0.04 |
Beta | 0.612 |
Volatility | 26.40% |
Current Volume | 202.4k |
Average Volume 20d | 230.8k |
As of May 02, 2025, the stock is trading at USD 156.88 with a total of 202,432 shares traded.
Over the past week, the price has changed by +1.74%, over one month by -6.19%, over three months by -2.49% and over the past year by +9.65%.
Partly, yes. Based on ValueRay Fundamental Analyses, Balchem (NASDAQ:BCPC) is currently (May 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 56.42 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BCPC as of May 2025 is 149.43. This means that BCPC is currently overvalued and has a potential downside of -4.75%.
Balchem has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy BCPC.
- Strong Buy: 0
- Buy: 2
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, BCPC Balchem will be worth about 166.6 in May 2026. The stock is currently trading at 156.88. This means that the stock has a potential upside of +6.18%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 196.7 | 25.4% |
Analysts Target Price | 199.3 | 27.1% |
ValueRay Target Price | 166.6 | 6.2% |